Table 3 The relationship between moesin expression and clinicopathological features of LUAD patients
Feature | Moesin | P value | |
|---|---|---|---|
High (n = 18) | Low (n = 72) | ||
Gender | P = 0.034 | ||
Male | 6 (33.33%) | 44 (61.11%) | |
Female | 12 (66.67%) | 28 (38.89%) | |
Age at diagnosis | P = 0.596 | ||
< 60 | 9 (50.00%) | 31 (43.06%) | |
≥ 60 | 9 (50.00%) | 41 (56.94%) | |
Location | P = 0.671 | ||
Left | 7 (38.89%) | 32 (44.44%) | |
Right | 11 (61.11%) | 40 (55.56%) | |
T stage | P = 0.039 | ||
T1–2 | 11 (61.11%) | 60 (83.33%) | |
T3–4 | 7 (38.89%) | 12 (16.67%) | |
N stage | P = 0.028 | ||
N0 | 11 (73.33%) | 25 (41.67%) | |
N1–3 | 4 (26.67%) | 35 (58.33%) | |
TNM stage | P = 0.023 | ||
I | 4 (22.22%) | 37 (52.11%) | |
II + III | 14 (77.78%) | 34 (47.89%) | |
Histological grade | P = 0.309 | ||
Well | 3 (16.67%) | 6 (8.57%) | |
Moderate | 11 (61.11%) | 55 (78.57%) | |
Poor | 4 (22.22%) | 9 (12.86%) | |